MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
Axonis
Axonis

Spinal cord injury (SCI) is a devastating medical condition that causes paralysis, with no effective treatment to restore movement or sensation to patients. Axonis has assembled top experts in the field to develop iPTEN, a pioneering regenerative therapy. iPTEN re-programs severed nerves to stimulate regeneration, leading to functional recovery. Our goal is to complete safety and efficacy studies in primates to launch iPTEN clinical trials by 2021.
Axonis translates breakthrough regeneration research to groundbreaking paralysis therapy, to transform lives of spinal cord injury patients.

Connect with Axonis

2019

2019 Finalist Boston

Sub industry

Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.